Approval · Notice of Compliance 19014 · 2017
FLUVIRAL: Notice of Compliance 19014
Issued March 1, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19014
- Date
- March 1, 2017
- Company
- Id Biomedical Corporation Of QuebecQuebec, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUVIRAL | Not yet assigned | — |
Medicinal ingredients
- HAEMAGGLUTININ-STRAIN A(H1N1) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN A(H3N2) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN B(VICTORIA) 15 MG per 0.5ML